Potent GCN2 Inhibitor Capable of Reversing MDSC-Driven T Cell Suppression Demonstrates In Vivo Efficacy as a Single Agent and in Combination with Anti-Angiogenesis TherapyJeffrey J. Jackson, Mikhail Zibinsky, Jacob B. Schwarz et al.|Journal of Medicinal Chemistry|2022Cited by 12
Abstract 2654: HPK1 inhibits CD8+ T cell effector gene expression following T cell activationRachel Y. Ames, Dirk G. Brockstedt, Blanca Gomez et al.|Cancer Research|2024Cited by 0